Refine by
Bleeding Control Articles & Analysis
18 news found
A comparison was made between a control group having no embolic treatment to treatment groups that received embolization with Embrace HES, gel foam slurry, or coils. Under coagulopathic conditions, Embrace HES showed improved survival time and a significant reduction in bleeding compared to the control group, gel foam slurry, and coil treatments. ...
Amsel Medical did not invent blood vessel occlusion or ligation. The first recorded attempt to control bleeding vessels by ligation dates back 3,000 years. The principle of ligation is attributed to Hippocrates and his disciples in Ancient Greece around 500 BCE. Little medical innovation occurred during the fifth to 15th centuries where the standard for wound ...
RevMedx, Inc., a global leader in innovative devices that control severe bleeding, today announced it has received CE (Conformité Européenne) Mark Certification for the XGAUZE wound dressing in Europe. ...
ByRevMedx
Historically many patients have opted for blood thinners to reduce this risk, but these come with an increased risk of bleeding and can require dietary restrictions and frequent blood tests for monitoring. ...
Pfizer Inc. (NYSE: PFE) and Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicines company, today announced updated follow-up data from the Phase 1/2 Alta study of giroctocogene fitelparvovec, an investigational gene therapy for patients with moderately severe to severe hemophilia A. The Alta study data, in patients with severe hemophilia A, are being presented today at the 63rd American ...
Axio Biosolutions, an integrated wound care company has announced FDA 510(k) clearance of its hemostatic product, Axiostat Patch that helps control moderate to severe bleeding in vascular procedures, surgical debridement sites, puncture sites and more. Axiostat Hemostatic Patch is based on a protonated bioadhesive technology which works by providing a strong ...
ACTISEAL® functions both as a sealant, withstanding the impact of aggressive bile and pancreatic fluids, and a hemostat, controlling mild-to-moderate bleeding. The easy-to-use, 100% synthetic device is optimized to adhere to and seal the treated tissue throughout the critical healing period following HPB surgery. ...
ByRegenity
The patch functions both as a sealant, withstanding the impact of aggressive bile and pancreatic fluids, and as a hemostat, controlling mild-to-moderate bleeding. It is being developed in close association with the surgical department of the University Medical Center Hamburg-Eppendorf (UKE), Germany, and with MercachemSyncom, a contract research organization ...
ByRegenity
In the new market scenario FVIII/VWF concentrates still play a key role to prevent and treat bleeds, and for the prevention and eradication of inhibitors. The company’s commitment to ensure product availability for all patients and the efforts to position Grifols factor VIII products in the new competitive landscape led to a stabilization in our sales volume. ...
In collaboration with surgeons and biomaterial scientists, EPI developed a breakthrough technology to control bleeding in the gastrointestinal tract by spraying a unique and proprietary powder directly on the wound. ...
According to the Centers for Disease Control and Prevention (CDC), 60 percent of pregnancy-related deaths are preventable. ...
Endomedix, Inc., today announced that it will present its patented revolutionary technology to control bleeding in battlefield injuries at the upcoming Military Health System and Research Symposium (MHSRS) annual meeting. Loss of blood still remains the most common cause of potentially preventable deaths in battlefield casualties, two-thirds of such deaths ...
Researchers at Mount Sinai Hospital (New York, NY) studied over 7,600 deliveries and concluded in “The association between the introduction of quantitative assessment of postpartum blood loss and institutional changes in clinical practice: an observational study” (Katz D, et al.) that the systematic monitoring of blood loss with Triton was associated with improved recognition of ...
RevMedx, Inc., a leader in groundbreaking solutions for the control of severe bleeding, today announced that the CoTCCC has added the TX Series ratcheting tourniquets to its list of recommended Limb Tourniquets. The TX series joins the XSTAT® injectable hemostatic on the TCCC list of recommended hemorrhage control devices for casualty care. ...
ByRevMedx
“The adhesiveness and long-lasting properties of EndoClot® Adhesive make it an ideal solution for bleeding control and the reduction of post procedure re-bleeding,” said James Ji, Founder of EndoClot Plus. ...
Revolutionary bleeding control technology will now be available in Europe and other International markets. RevMedx, Inc., a leader in innovative devices that control severe bleeding, today announced it has received CE (Conformité Européenne) Mark Certification for the XSTAT 30 and XSTAT 12 hemostatic devices in ...
ByRevMedx
While building a platform technology, Russo directed Endomedix towards commercializing its first product, a gel spray that controls bleeding during ...
By relocating to the Newark-based university, the company has been able to tap into the institution’s human and financial resources, allowing it to keep costs at a minimum as it develops its product: a spray gel used to control bleeding during brain ...